thousands of women whose breast cancer has become resistant to standard treatment could benefit from a new drug combination , claim researchers . it is hoped the new approach will target cancer stem cells that evade conventional drugs and cause the tumour to re-grow . previous research has found women with higher blood sugar levels are more likely to develop cancer , even if they do n't have diabetes . this combination of drugs potentially allows us to target oestrogen-sensitive cells , while also mopping up the cells which cause treatment resistance . â€™